nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—ABCB1—Levothyroxine—hypothyroidism	0.115	0.28	CbGbCtD
Betamethasone—ABCB1—Liothyronine—hypothyroidism	0.115	0.28	CbGbCtD
Betamethasone—ABCB1—Liotrix—hypothyroidism	0.112	0.273	CbGbCtD
Betamethasone—CYP3A4—Levothyroxine—hypothyroidism	0.069	0.168	CbGbCtD
Betamethasone—PGR—corpus luteum—hypothyroidism	0.0281	0.145	CbGeAlD
Betamethasone—CYP19A1—corpus luteum—hypothyroidism	0.0253	0.13	CbGeAlD
Betamethasone—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0215	0.111	CbGeAlD
Betamethasone—Benign intracranial hypertension—Dextrothyroxine—hypothyroidism	0.0129	0.0443	CcSEcCtD
Betamethasone—Benign intracranial hypertension—Levothyroxine—hypothyroidism	0.0129	0.0443	CcSEcCtD
Betamethasone—Water retention—Liotrix—hypothyroidism	0.0123	0.0422	CcSEcCtD
Betamethasone—Benign intracranial hypertension—Liotrix—hypothyroidism	0.00948	0.0326	CcSEcCtD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00805	0.0793	CbGpPWpGaD
Betamethasone—NR3C2—Preimplantation Embryo—DLX2—hypothyroidism	0.00726	0.0716	CbGpPWpGaD
Betamethasone—Menstruation irregular—Levothyroxine—hypothyroidism	0.00684	0.0235	CcSEcCtD
Betamethasone—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00684	0.0235	CcSEcCtD
Betamethasone—PGR—Nuclear Receptors—THRA—hypothyroidism	0.0062	0.0611	CbGpPWpGaD
Betamethasone—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00618	0.0212	CcSEcCtD
Betamethasone—NR3C1—urine—hypothyroidism	0.00531	0.0274	CbGeAlD
Betamethasone—Hypernatraemia—Liotrix—hypothyroidism	0.0053	0.0182	CcSEcCtD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00519	0.0511	CbGpPWpGaD
Betamethasone—PLA2G1B—heart—hypothyroidism	0.00512	0.0264	CbGeAlD
Betamethasone—Menstruation irregular—Liotrix—hypothyroidism	0.00503	0.0173	CcSEcCtD
Betamethasone—NR3C2—Preimplantation Embryo—NKX2-1—hypothyroidism	0.0049	0.0483	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0049	0.0483	CbGpPWpGaD
Betamethasone—PLA2G1B—cardiovascular system—hypothyroidism	0.00483	0.0249	CbGeAlD
Betamethasone—PLA2G1B—pituitary gland—hypothyroidism	0.00428	0.022	CbGeAlD
Betamethasone—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00425	0.0146	CcSEcCtD
Betamethasone—Myocardial infarction—Liothyronine—hypothyroidism	0.00423	0.0145	CcSEcCtD
Betamethasone—CYP3A4—urine—hypothyroidism	0.00402	0.0207	CbGeAlD
Betamethasone—PGR—Nuclear Receptors—THRB—hypothyroidism	0.004	0.0394	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.00397	0.0391	CbGpPWpGaD
Betamethasone—PLA2G1B—adrenal gland—hypothyroidism	0.00382	0.0197	CbGeAlD
Betamethasone—PLA2G1B—blood—hypothyroidism	0.00382	0.0197	CbGeAlD
Betamethasone—NR3C1—nerve—hypothyroidism	0.00366	0.0189	CbGeAlD
Betamethasone—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.00358	0.0353	CbGpPWpGaD
Betamethasone—PLA2G1B—female gonad—hypothyroidism	0.00356	0.0184	CbGeAlD
Betamethasone—Necrosis—Liotrix—hypothyroidism	0.00355	0.0122	CcSEcCtD
Betamethasone—Abscess—Liotrix—hypothyroidism	0.00352	0.0121	CcSEcCtD
Betamethasone—Tingling sensation—Liotrix—hypothyroidism	0.00347	0.0119	CcSEcCtD
Betamethasone—Arrhythmia—Liothyronine—hypothyroidism	0.00346	0.0119	CcSEcCtD
Betamethasone—Extravasation—Liotrix—hypothyroidism	0.00319	0.011	CcSEcCtD
Betamethasone—PLA2G1B—testis—hypothyroidism	0.00316	0.0163	CbGeAlD
Betamethasone—PGR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00316	0.0311	CbGpPWpGaD
Betamethasone—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00303	0.0104	CcSEcCtD
Betamethasone—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00303	0.0104	CcSEcCtD
Betamethasone—Ulcer—Liotrix—hypothyroidism	0.00295	0.0101	CcSEcCtD
Betamethasone—Increased appetite—Levothyroxine—hypothyroidism	0.00293	0.0101	CcSEcCtD
Betamethasone—Increased appetite—Dextrothyroxine—hypothyroidism	0.00293	0.0101	CcSEcCtD
Betamethasone—Hypertension—Liothyronine—hypothyroidism	0.00291	0.01	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00283	0.0279	CbGpPWpGaD
Betamethasone—Cardiac failure—Levothyroxine—hypothyroidism	0.00282	0.00969	CcSEcCtD
Betamethasone—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00282	0.00969	CcSEcCtD
Betamethasone—Affect lability—Levothyroxine—hypothyroidism	0.00271	0.0093	CcSEcCtD
Betamethasone—Affect lability—Dextrothyroxine—hypothyroidism	0.00271	0.0093	CcSEcCtD
Betamethasone—Tachycardia—Liothyronine—hypothyroidism	0.00269	0.00923	CcSEcCtD
Betamethasone—Fluid retention—Liotrix—hypothyroidism	0.00265	0.00909	CcSEcCtD
Betamethasone—Irritability—Levothyroxine—hypothyroidism	0.00263	0.00902	CcSEcCtD
Betamethasone—Irritability—Dextrothyroxine—hypothyroidism	0.00263	0.00902	CcSEcCtD
Betamethasone—NR3C2—adrenal cortex—hypothyroidism	0.00262	0.0135	CbGeAlD
Betamethasone—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00262	0.00899	CcSEcCtD
Betamethasone—Cardiac arrest—Levothyroxine—hypothyroidism	0.00262	0.00899	CcSEcCtD
Betamethasone—Mood swings—Levothyroxine—hypothyroidism	0.00261	0.00896	CcSEcCtD
Betamethasone—Mood swings—Dextrothyroxine—hypothyroidism	0.00261	0.00896	CcSEcCtD
Betamethasone—Hypotension—Liothyronine—hypothyroidism	0.00257	0.00884	CcSEcCtD
Betamethasone—NR3C2—heart—hypothyroidism	0.00254	0.0131	CbGeAlD
Betamethasone—Muscular weakness—Levothyroxine—hypothyroidism	0.00243	0.00834	CcSEcCtD
Betamethasone—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00243	0.00834	CcSEcCtD
Betamethasone—NR3C2—cardiovascular system—hypothyroidism	0.00239	0.0123	CbGeAlD
Betamethasone—PGR—heart—hypothyroidism	0.00236	0.0121	CbGeAlD
Betamethasone—Sweating increased—Levothyroxine—hypothyroidism	0.00232	0.00796	CcSEcCtD
Betamethasone—Sweating increased—Dextrothyroxine—hypothyroidism	0.00232	0.00796	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptors—THRB—hypothyroidism	0.00231	0.0228	CbGpPWpGaD
Betamethasone—Cardiac failure congestive—Liotrix—hypothyroidism	0.00223	0.00767	CcSEcCtD
Betamethasone—PGR—cardiovascular system—hypothyroidism	0.00222	0.0115	CbGeAlD
Betamethasone—Body temperature increased—Liothyronine—hypothyroidism	0.00218	0.00748	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00216	0.0213	CbGpPWpGaD
Betamethasone—Increased appetite—Liotrix—hypothyroidism	0.00215	0.0074	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00215	0.0212	CbGpPWpGaD
Betamethasone—Weight decreased—Levothyroxine—hypothyroidism	0.00215	0.00739	CcSEcCtD
Betamethasone—Weight decreased—Dextrothyroxine—hypothyroidism	0.00215	0.00739	CcSEcCtD
Betamethasone—NR3C2—pituitary gland—hypothyroidism	0.00212	0.0109	CbGeAlD
Betamethasone—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00209	0.00718	CcSEcCtD
Betamethasone—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00209	0.00718	CcSEcCtD
Betamethasone—Myocardial infarction—Levothyroxine—hypothyroidism	0.00208	0.00714	CcSEcCtD
Betamethasone—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00208	0.00714	CcSEcCtD
Betamethasone—Cardiac failure—Liotrix—hypothyroidism	0.00207	0.00713	CcSEcCtD
Betamethasone—Affect lability—Liotrix—hypothyroidism	0.00199	0.00684	CcSEcCtD
Betamethasone—PGR—pituitary gland—hypothyroidism	0.00197	0.0101	CbGeAlD
Betamethasone—Irritability—Liotrix—hypothyroidism	0.00193	0.00664	CcSEcCtD
Betamethasone—Cardiac arrest—Liotrix—hypothyroidism	0.00192	0.00661	CcSEcCtD
Betamethasone—Mood swings—Liotrix—hypothyroidism	0.00192	0.00659	CcSEcCtD
Betamethasone—NR3C2—adrenal gland—hypothyroidism	0.00189	0.00975	CbGeAlD
Betamethasone—NR3C2—blood—hypothyroidism	0.00189	0.00975	CbGeAlD
Betamethasone—Hypokalaemia—Liotrix—hypothyroidism	0.00184	0.00633	CcSEcCtD
Betamethasone—NR3C2—thyroid gland—hypothyroidism	0.00183	0.00941	CbGeAlD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00183	0.018	CbGpPWpGaD
Betamethasone—CYP19A1—gonad—hypothyroidism	0.00182	0.00936	CbGeAlD
Betamethasone—Muscular weakness—Liotrix—hypothyroidism	0.00178	0.00613	CcSEcCtD
Betamethasone—NR3C2—female gonad—hypothyroidism	0.00177	0.00909	CbGeAlD
Betamethasone—PGR—adrenal gland—hypothyroidism	0.00176	0.00907	CbGeAlD
Betamethasone—PGR—blood—hypothyroidism	0.00176	0.00906	CbGeAlD
Betamethasone—PGR—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.00175	0.0172	CbGpPWpGaD
Betamethasone—Sweating increased—Liotrix—hypothyroidism	0.0017	0.00585	CcSEcCtD
Betamethasone—Arrhythmia—Levothyroxine—hypothyroidism	0.0017	0.00584	CcSEcCtD
Betamethasone—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0017	0.00584	CcSEcCtD
Betamethasone—PGR—thyroid gland—hypothyroidism	0.0017	0.00875	CbGeAlD
Betamethasone—Alopecia—Levothyroxine—hypothyroidism	0.00168	0.00578	CcSEcCtD
Betamethasone—Alopecia—Dextrothyroxine—hypothyroidism	0.00168	0.00578	CcSEcCtD
Betamethasone—PGR—female gonad—hypothyroidism	0.00164	0.00845	CbGeAlD
Betamethasone—CYP19A1—adrenal gland—hypothyroidism	0.00158	0.00816	CbGeAlD
Betamethasone—CYP19A1—blood—hypothyroidism	0.00158	0.00816	CbGeAlD
Betamethasone—Weight decreased—Liotrix—hypothyroidism	0.00158	0.00544	CcSEcCtD
Betamethasone—NR3C2—testis—hypothyroidism	0.00157	0.00807	CbGeAlD
Betamethasone—PLA2G1B—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00154	0.0152	CbGpPWpGaD
Betamethasone—Acute coronary syndrome—Liotrix—hypothyroidism	0.00154	0.00528	CcSEcCtD
Betamethasone—Myocardial infarction—Liotrix—hypothyroidism	0.00153	0.00525	CcSEcCtD
Betamethasone—CYP19A1—thyroid gland—hypothyroidism	0.00153	0.00787	CbGeAlD
Betamethasone—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	0.00152	0.015	CbGpPWpGaD
Betamethasone—Angioedema—Dextrothyroxine—hypothyroidism	0.00151	0.0052	CcSEcCtD
Betamethasone—Angioedema—Levothyroxine—hypothyroidism	0.00151	0.0052	CcSEcCtD
Betamethasone—NR3C2—liver—hypothyroidism	0.00148	0.00763	CbGeAlD
Betamethasone—CYP19A1—female gonad—hypothyroidism	0.00148	0.00761	CbGeAlD
Betamethasone—PGR—testis—hypothyroidism	0.00146	0.0075	CbGeAlD
Betamethasone—NR3C2—cerebellum—hypothyroidism	0.00145	0.00745	CbGeAlD
Betamethasone—Convulsion—Dextrothyroxine—hypothyroidism	0.00144	0.00493	CcSEcCtD
Betamethasone—Convulsion—Levothyroxine—hypothyroidism	0.00144	0.00493	CcSEcCtD
Betamethasone—NR3C1—adrenal cortex—hypothyroidism	0.00141	0.00725	CbGeAlD
Betamethasone—Anxiety—Dextrothyroxine—hypothyroidism	0.00141	0.00483	CcSEcCtD
Betamethasone—Anxiety—Levothyroxine—hypothyroidism	0.00141	0.00483	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00139	0.0137	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—THRA—hypothyroidism	0.00139	0.0137	CbGpPWpGaD
Betamethasone—NR3C1—heart—hypothyroidism	0.00136	0.00701	CbGeAlD
Betamethasone—PGR—cerebellum—hypothyroidism	0.00134	0.00692	CbGeAlD
Betamethasone—Shock—Dextrothyroxine—hypothyroidism	0.00133	0.00457	CcSEcCtD
Betamethasone—Shock—Levothyroxine—hypothyroidism	0.00133	0.00457	CcSEcCtD
Betamethasone—Tachycardia—Levothyroxine—hypothyroidism	0.00132	0.00453	CcSEcCtD
Betamethasone—Tachycardia—Dextrothyroxine—hypothyroidism	0.00132	0.00453	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00131	0.013	CbGpPWpGaD
Betamethasone—CYP19A1—testis—hypothyroidism	0.00131	0.00675	CbGeAlD
Betamethasone—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00131	0.00449	CcSEcCtD
Betamethasone—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00131	0.00449	CcSEcCtD
Betamethasone—NR3C1—cardiovascular system—hypothyroidism	0.00128	0.00661	CbGeAlD
Betamethasone—Arrhythmia—Liotrix—hypothyroidism	0.00125	0.0043	CcSEcCtD
Betamethasone—CYP19A1—liver—hypothyroidism	0.00124	0.00638	CbGeAlD
Betamethasone—Alopecia—Liotrix—hypothyroidism	0.00124	0.00425	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00123	0.00423	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00123	0.00423	CcSEcCtD
Betamethasone—Insomnia—Levothyroxine—hypothyroidism	0.00122	0.0042	CcSEcCtD
Betamethasone—Insomnia—Dextrothyroxine—hypothyroidism	0.00122	0.0042	CcSEcCtD
Betamethasone—PTGS2—adrenal cortex—hypothyroidism	0.00122	0.00627	CbGeAlD
Betamethasone—PTGS2—heart—hypothyroidism	0.00118	0.00607	CbGeAlD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00118	0.0116	CbGpPWpGaD
Betamethasone—Fatigue—Dextrothyroxine—hypothyroidism	0.00117	0.00401	CcSEcCtD
Betamethasone—Fatigue—Levothyroxine—hypothyroidism	0.00117	0.00401	CcSEcCtD
Betamethasone—NR3C1—gonad—hypothyroidism	0.00117	0.006	CbGeAlD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00116	0.0114	CbGpPWpGaD
Betamethasone—Fluoxymesterone—SHBG—hypothyroidism	0.00114	0.622	CrCbGaD
Betamethasone—NR3C1—pituitary gland—hypothyroidism	0.00114	0.00586	CbGeAlD
Betamethasone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00111	0.00383	CcSEcCtD
Betamethasone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00111	0.00383	CcSEcCtD
Betamethasone—Angioedema—Liotrix—hypothyroidism	0.00111	0.00383	CcSEcCtD
Betamethasone—PTGS2—cardiovascular system—hypothyroidism	0.00111	0.00572	CbGeAlD
Betamethasone—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00111	0.0038	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00111	0.0038	CcSEcCtD
Betamethasone—Syncope—Liotrix—hypothyroidism	0.00109	0.00376	CcSEcCtD
Betamethasone—Urticaria—Dextrothyroxine—hypothyroidism	0.00107	0.00369	CcSEcCtD
Betamethasone—Urticaria—Levothyroxine—hypothyroidism	0.00107	0.00369	CcSEcCtD
Betamethasone—Loss of consciousness—Liotrix—hypothyroidism	0.00107	0.00368	CcSEcCtD
Betamethasone—Abdominal pain—Levothyroxine—hypothyroidism	0.00107	0.00367	CcSEcCtD
Betamethasone—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00107	0.00367	CcSEcCtD
Betamethasone—Body temperature increased—Levothyroxine—hypothyroidism	0.00107	0.00367	CcSEcCtD
Betamethasone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00107	0.00367	CcSEcCtD
Betamethasone—Convulsion—Liotrix—hypothyroidism	0.00106	0.00363	CcSEcCtD
Betamethasone—Hypertension—Liotrix—hypothyroidism	0.00105	0.00362	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—ZNF764—hypothyroidism	0.00104	0.0102	CbGpPWpGaD
Betamethasone—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.00104	0.0102	CbGpPWpGaD
Betamethasone—Anxiety—Liotrix—hypothyroidism	0.00103	0.00355	CcSEcCtD
Betamethasone—NR3C1—adrenal gland—hypothyroidism	0.00102	0.00523	CbGeAlD
Betamethasone—NR3C1—blood—hypothyroidism	0.00102	0.00523	CbGeAlD
Betamethasone—Oedema—Liotrix—hypothyroidism	0.000994	0.00342	CcSEcCtD
Betamethasone—Anaphylactic shock—Liotrix—hypothyroidism	0.000994	0.00342	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00099	0.00976	CbGpPWpGaD
Betamethasone—Infection—Liotrix—hypothyroidism	0.000988	0.0034	CcSEcCtD
Betamethasone—PTGS2—pituitary gland—hypothyroidism	0.000984	0.00507	CbGeAlD
Betamethasone—NR3C1—thyroid gland—hypothyroidism	0.00098	0.00505	CbGeAlD
Betamethasone—Shock—Liotrix—hypothyroidism	0.000978	0.00336	CcSEcCtD
Betamethasone—Tachycardia—Liotrix—hypothyroidism	0.000971	0.00334	CcSEcCtD
Betamethasone—Asthenia—Dextrothyroxine—hypothyroidism	0.00097	0.00333	CcSEcCtD
Betamethasone—Asthenia—Levothyroxine—hypothyroidism	0.00097	0.00333	CcSEcCtD
Betamethasone—Hyperhidrosis—Liotrix—hypothyroidism	0.000961	0.0033	CcSEcCtD
Betamethasone—Pruritus—Dextrothyroxine—hypothyroidism	0.000956	0.00329	CcSEcCtD
Betamethasone—Pruritus—Levothyroxine—hypothyroidism	0.000956	0.00329	CcSEcCtD
Betamethasone—Anorexia—Liotrix—hypothyroidism	0.000948	0.00326	CcSEcCtD
Betamethasone—NR3C1—female gonad—hypothyroidism	0.000947	0.00488	CbGeAlD
Betamethasone—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.000945	0.00931	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.000939	0.00926	CbGpPWpGaD
Betamethasone—Hypotension—Liotrix—hypothyroidism	0.000929	0.00319	CcSEcCtD
Betamethasone—Diarrhoea—Levothyroxine—hypothyroidism	0.000925	0.00318	CcSEcCtD
Betamethasone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000925	0.00318	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000906	0.00311	CcSEcCtD
Betamethasone—Insomnia—Liotrix—hypothyroidism	0.000899	0.00309	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—THRB—hypothyroidism	0.000896	0.00883	CbGpPWpGaD
Betamethasone—Paraesthesia—Liotrix—hypothyroidism	0.000893	0.00307	CcSEcCtD
Betamethasone—PTGS2—adrenal gland—hypothyroidism	0.000879	0.00453	CbGeAlD
Betamethasone—PTGS2—blood—hypothyroidism	0.000879	0.00453	CbGeAlD
Betamethasone—Decreased appetite—Liotrix—hypothyroidism	0.000864	0.00297	CcSEcCtD
Betamethasone—Vomiting—Dextrothyroxine—hypothyroidism	0.00086	0.00295	CcSEcCtD
Betamethasone—Vomiting—Levothyroxine—hypothyroidism	0.00086	0.00295	CcSEcCtD
Betamethasone—Fatigue—Liotrix—hypothyroidism	0.000857	0.00295	CcSEcCtD
Betamethasone—Rash—Levothyroxine—hypothyroidism	0.000852	0.00293	CcSEcCtD
Betamethasone—Rash—Dextrothyroxine—hypothyroidism	0.000852	0.00293	CcSEcCtD
Betamethasone—Dermatitis—Dextrothyroxine—hypothyroidism	0.000852	0.00293	CcSEcCtD
Betamethasone—Dermatitis—Levothyroxine—hypothyroidism	0.000852	0.00293	CcSEcCtD
Betamethasone—Headache—Dextrothyroxine—hypothyroidism	0.000847	0.00291	CcSEcCtD
Betamethasone—Headache—Levothyroxine—hypothyroidism	0.000847	0.00291	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—THRA—hypothyroidism	0.000847	0.00834	CbGpPWpGaD
Betamethasone—NR3C1—testis—hypothyroidism	0.00084	0.00433	CbGeAlD
Betamethasone—Feeling abnormal—Liotrix—hypothyroidism	0.000819	0.00282	CcSEcCtD
Betamethasone—PTGS2—female gonad—hypothyroidism	0.000819	0.00422	CbGeAlD
Betamethasone—Gastrointestinal pain—Liotrix—hypothyroidism	0.000813	0.00279	CcSEcCtD
Betamethasone—Nausea—Levothyroxine—hypothyroidism	0.000803	0.00276	CcSEcCtD
Betamethasone—Nausea—Dextrothyroxine—hypothyroidism	0.000803	0.00276	CcSEcCtD
Betamethasone—NR3C1—liver—hypothyroidism	0.000794	0.00409	CbGeAlD
Betamethasone—Urticaria—Liotrix—hypothyroidism	0.00079	0.00272	CcSEcCtD
Betamethasone—Abdominal pain—Liotrix—hypothyroidism	0.000786	0.0027	CcSEcCtD
Betamethasone—Body temperature increased—Liotrix—hypothyroidism	0.000786	0.0027	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.000776	0.00765	CbGpPWpGaD
Betamethasone—NR3C1—cerebellum—hypothyroidism	0.000776	0.004	CbGeAlD
Betamethasone—CYP3A4—blood—hypothyroidism	0.000768	0.00396	CbGeAlD
Betamethasone—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000759	0.00749	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.000756	0.00746	CbGpPWpGaD
Betamethasone—ABCB1—adrenal cortex—hypothyroidism	0.000753	0.00388	CbGeAlD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000746	0.00736	CbGpPWpGaD
Betamethasone—ABCB1—heart—hypothyroidism	0.000728	0.00375	CbGeAlD
Betamethasone—Asthenia—Liotrix—hypothyroidism	0.000713	0.00245	CcSEcCtD
Betamethasone—Pruritus—Liotrix—hypothyroidism	0.000704	0.00242	CcSEcCtD
Betamethasone—Hydrocortisone—SHBG—hypothyroidism	0.000694	0.378	CrCbGaD
Betamethasone—ABCB1—cardiovascular system—hypothyroidism	0.000687	0.00354	CbGeAlD
Betamethasone—PTGS2—liver—hypothyroidism	0.000687	0.00354	CbGeAlD
Betamethasone—NR3C1—Circadian Clock—AVP—hypothyroidism	0.000684	0.00674	CbGpPWpGaD
Betamethasone—Diarrhoea—Liotrix—hypothyroidism	0.00068	0.00234	CcSEcCtD
Betamethasone—PTGS2—cerebellum—hypothyroidism	0.000671	0.00346	CbGeAlD
Betamethasone—NR3C2—Gene Expression—THRA—hypothyroidism	0.000669	0.0066	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—IYD—hypothyroidism	0.000669	0.0066	CbGpPWpGaD
Betamethasone—Dizziness—Liotrix—hypothyroidism	0.000658	0.00226	CcSEcCtD
Betamethasone—PGR—Gene Expression—ZNF764—hypothyroidism	0.000632	0.00623	CbGpPWpGaD
Betamethasone—Vomiting—Liotrix—hypothyroidism	0.000632	0.00217	CcSEcCtD
Betamethasone—Rash—Liotrix—hypothyroidism	0.000627	0.00215	CcSEcCtD
Betamethasone—Dermatitis—Liotrix—hypothyroidism	0.000626	0.00215	CcSEcCtD
Betamethasone—ABCB1—gonad—hypothyroidism	0.000624	0.00321	CbGeAlD
Betamethasone—Headache—Liotrix—hypothyroidism	0.000623	0.00214	CcSEcCtD
Betamethasone—ABCB1—pituitary gland—hypothyroidism	0.000608	0.00313	CbGeAlD
Betamethasone—PGR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000603	0.00595	CbGpPWpGaD
Betamethasone—CYP3A4—liver—hypothyroidism	0.0006	0.00309	CbGeAlD
Betamethasone—Nausea—Liotrix—hypothyroidism	0.000591	0.00203	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—PRL—hypothyroidism	0.000589	0.0058	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ATP5O—hypothyroidism	0.000569	0.00561	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.000558	0.0055	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—THRB—hypothyroidism	0.000545	0.00538	CbGpPWpGaD
Betamethasone—ABCB1—adrenal gland—hypothyroidism	0.000544	0.0028	CbGeAlD
Betamethasone—ABCB1—blood—hypothyroidism	0.000543	0.0028	CbGeAlD
Betamethasone—PLA2G1B—Metabolism—TPO—hypothyroidism	0.000535	0.00527	CbGpPWpGaD
Betamethasone—ABCB1—thyroid gland—hypothyroidism	0.000525	0.0027	CbGeAlD
Betamethasone—ABCB1—female gonad—hypothyroidism	0.000507	0.00261	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000496	0.00489	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	0.000489	0.00482	CbGpPWpGaD
Betamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000481	0.00474	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NKX2-5—hypothyroidism	0.000477	0.0047	CbGpPWpGaD
Betamethasone—ABCB1—testis—hypothyroidism	0.00045	0.00232	CbGeAlD
Betamethasone—NR3C2—Gene Expression—THRB—hypothyroidism	0.000431	0.00425	CbGpPWpGaD
Betamethasone—ABCB1—liver—hypothyroidism	0.000425	0.00219	CbGeAlD
Betamethasone—ABCB1—cerebellum—hypothyroidism	0.000415	0.00214	CbGeAlD
Betamethasone—PGR—Gene Expression—THRA—hypothyroidism	0.000408	0.00402	CbGpPWpGaD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00039	0.00384	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZNF764—hypothyroidism	0.000366	0.0036	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000349	0.00344	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.00033	0.00326	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	0.000315	0.00311	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000297	0.00293	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NKX2-5—hypothyroidism	0.00029	0.00286	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—THRB—hypothyroidism	0.000263	0.00259	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TSHB—hypothyroidism	0.000248	0.00244	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—IYD—hypothyroidism	0.000244	0.00241	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—THRA—hypothyroidism	0.000236	0.00232	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3C2A—hypothyroidism	0.000221	0.00218	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IGF1—hypothyroidism	0.00022	0.00217	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000218	0.00215	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000208	0.00205	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000207	0.00204	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TPO—hypothyroidism	0.000195	0.00193	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SLC5A5—hypothyroidism	0.000185	0.00183	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000181	0.00178	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000171	0.00169	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NKX2-5—hypothyroidism	0.000168	0.00165	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—IYD—hypothyroidism	0.000163	0.00161	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—THRB—hypothyroidism	0.000152	0.0015	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CLTC—hypothyroidism	0.00015	0.00148	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000142	0.0014	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00014	0.00138	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ATP5O—hypothyroidism	0.000139	0.00137	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TPO—hypothyroidism	0.000131	0.00129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TRH—hypothyroidism	0.000129	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000122	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000121	0.00119	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IYD—hypothyroidism	0.000116	0.00114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSHB—hypothyroidism	0.000115	0.00114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSHR—hypothyroidism	0.000115	0.00114	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000114	0.00112	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SH2B3—hypothyroidism	0.000103	0.00101	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ATP5O—hypothyroidism	9.84e-05	0.00097	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—POMC—hypothyroidism	9.7e-05	0.000956	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TPO—hypothyroidism	9.25e-05	0.000912	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TSHB—hypothyroidism	9.04e-05	0.000891	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.68e-05	0.000855	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	8.06e-05	0.000795	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.95e-05	0.000784	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRL—hypothyroidism	7.63e-05	0.000752	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IYD—hypothyroidism	7.13e-05	0.000703	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VAV3—hypothyroidism	7.06e-05	0.000696	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.85e-05	0.000675	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AVP—hypothyroidism	6.8e-05	0.00067	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—hypothyroidism	6.77e-05	0.000667	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.06e-05	0.000598	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.04e-05	0.000596	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TSHB—hypothyroidism	6.04e-05	0.000596	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TPO—hypothyroidism	5.7e-05	0.000562	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.39e-05	0.000531	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3C2A—hypothyroidism	5.39e-05	0.000531	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.31e-05	0.000524	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRL—hypothyroidism	4.77e-05	0.00047	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—hypothyroidism	4.52e-05	0.000446	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—hypothyroidism	4.52e-05	0.000445	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—hypothyroidism	4.35e-05	0.000428	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TSHB—hypothyroidism	4.28e-05	0.000422	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.82e-05	0.000376	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—hypothyroidism	3.54e-05	0.000349	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.21e-05	0.000316	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TSHB—hypothyroidism	2.64e-05	0.00026	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—hypothyroidism	2.37e-05	0.000233	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.35e-05	0.000232	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.98e-05	0.000195	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—hypothyroidism	1.68e-05	0.000165	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—hypothyroidism	1.03e-05	0.000102	CbGpPWpGaD
